Bruce DeSilva

IBN (InvestorBrandNetwork) Announces NetworkNewsAudio Interview featuring Suji Desilva, Senior Research Analyst at Roth Capital Partners

Retrieved on: 
Tuesday, March 1, 2022

The latest NetworkNewsAudio production features Suji Desilva, Senior Research Analyst at Roth Capital Partners , a relationship-driven, full-service investment bank that provides strategic and financial advisory services to emerging growth companies and their investors.

Key Points: 
  • The latest NetworkNewsAudio production features Suji Desilva, Senior Research Analyst at Roth Capital Partners , a relationship-driven, full-service investment bank that provides strategic and financial advisory services to emerging growth companies and their investors.
  • During the interview, Desilva discussed his experience since joining Roth Capital Partners, as well as provided an overview of the companys business model.
  • Join IBNs Jonathan Keim and Suji Desilva, Senior Research Analyst at Roth Capital Partners , to learn more about Roths operations, Desilvas focus on the emerging auto tech space and the 34th Annual Roth Conference , which is set to kick off this month.
  • As a full-service investment bank, Roth provides capital raising, M&A advisory, analytical research, trading, market-making services and corporate access.

Digital Medicine Society's Playbook Initiative Publishes Review of Digital Clinical Measures Research in JMIR

Retrieved on: 
Wednesday, September 15, 2021

"We rely on academic researchers to be the arbiters of new digital health products and ensure that this field, which is advancing so rapidly, is worthy of public trust," says Jennifer Goldsack, CEO of DiMe. "Outside of collaborations such as The Playbook that yielded this research, academic institutions are one of the few places that convene the interdisciplinary experts needed to bridge the growing chasm between the promised benefits of these measures and their potential risks. We found substantial research activity examining the underlying performance of digital measurement products -- verification of the sensors, analytical validation of the algorithms, and clinical validation, otherwise known as 'V3'. Now it's time to expand focus -- and funding -- to address the paucity of research addressing ethics, data rights, and cybersecurity."

Key Points: 
  • BOSTON, Sept. 15, 2021 /PRNewswire/ -- Today, a pre-competitive collaboration hosted by the Digital Medicine Society (DiMe) published data reporting the current state of research related to digital clinical measures and sources of funding.
  • This systematic review, published in the Journal of Medical Internet Research (JMIR) , identifies critical gaps in academic research related to digital clinical measures while adoption of digital health continues to soar.
  • This new research indicates that government agencies and independent foundations are funding most of the academic research studies related to digital clinical measures, with industry funding of these studies lagging behind.
  • About the Digital Medicine Society: The Digital Medicine Society (DiMe) is the professional society serving the digital medicine community, driving scientific progress and broad acceptance of digital medicine to enhance public health.